Clinical trial

Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual…

NCT00289926 · Monash University, Other · Completed

Key facts

NCT number NCT00289926
Title Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms
Official title A Randomised, Double-blind, Placebo-controlled, Parallel-group, 52-week Study to Evaluate the Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms
Lead sponsor Monash University, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Quality of Life, Menopausal Syndrome, Libido Disorder
Intervention type Drug
Interventions dehydroepiandrosterone, placebo
Enrollment 240
Start date Feb 1, 2006
Primary completion Apr 1, 2008
Completion Apr 1, 2008
First posted Feb 10, 2006
Last update posted Mar 16, 2016
Countries Australia

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies